Release 4B R5 Final QA

This page is part of the FHIR Specification (v4.3.0: R4B (v5.0.0-draft-final: Final QA Preview for R5 - STU see ballot notes ). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationrequest0317

Example MedicationRequest/medrx0317 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative Narrative: MedicationRequest

Resource MedicationRequest "medrx0317"

identifier : id: 12345689 (OFFICIAL) id: 12345689 (use: OFFICIAL)

status : completed

intent : order

Medications

- medication : Reference
*

Resource "med0303"

code : Alemtuzumab 10mg/ml (Lemtrada) ( RxNorm #1594660)

subject : Patient/pat1: Donald Duck "Duck DONALD" "Donald DUCK"

authoredOn : 2015-01-15

requester : Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

- reasonCode : Concept
* Chronic Lymphoid Leukemia (disorder) ( SNOMED CT #92814006)

dosageInstruction

sequence : 1

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

doseAndRate

dosageInstruction

sequence : 2

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

doseAndRate

dosageInstruction

sequence : 3

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 3 per 1 weeks

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

doseAndRate

 

Other examples that reference this example:

  • MedicationAdministration/IV Admin Not Given
  • MedicationDispense/IV Chemo

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.